Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In group 1, prevalence of CAN was 46% versus 75% in group 2 (p=0.01). 25(OH)D was lower in group 2 (26.3 ± 9.8 vs 30.0 ± 8.0; p<0.05) and, in this group, those with CAN vs without CAN showed lower 25(OH)D (27.8 ± 8.3 vs 32 ± 6.3; p<0.05).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This was a cross-sectional study designed to evaluate potential associations between serum VD concentrations and CAN in patients with T2DM at early and advanced stages of DKD.

Source: Methods.

All patients were followed at the Endocrinology Ambulatory and received orientation about diet and exercise according to American Diabetes Association (ADA) guidelines ().

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D and cardiovascular autonomic neuropathy in type 2 diabetes mellitus according to diabetic kidney disease stage

Cross-sectional study · Frontiers in Endocrinology · 2026

Original publication title

Vitamin D and cardiovascular autonomic neuropathy in type 2 diabetes mellitus according to diabetic kidney disease stage

João Felício; Ester Chambouleyron; Valéria Nascimento; Isabel Fernandes; Lícia Ruivo; Maria Vitória Hupp; Lilian Silva; Natércia de Queiroz; Franciane de Melo; Ana Carolina de Souza; Márcia dos Santos; Lorena de Moraes; Mayana Barros; Danielle Pinheiro; Maria Eduarda do Carmo; Beatriz Lobo; Pedro Piani; Ana Regina Motta; Melissa dos Reis; Valéria Suênya Leal; Priscila de Figueiredo; Karem Felício

Copyright © 2026 Felício, Chambouleyron, Nascimento, Fernandes, Ruivo, Hupp, Silva, de Queiroz, de Melo, de Souza, dos Santos, de Moraes, Barros, Pinheiro, do Carmo, Lobo, Piani, Motta, dos Reis, Leal, de Figueiredo and Felício.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

To our knowledge, this is the first study to demonstrate an association between lower VD and CAN in T2DM and advanced DKD.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/objectives

Cardiovascular autonomic neuropathy (CAN) may be associated with other diabetes mellitus-related complications. In addition, lower vitamin D (VD) levels have been associated with diabetic kidney disease (DKD) and diabetic neuropathy. We evaluated the relationship between serum VD and CAN in patients with type 2 Diabetes Mellitus (T2DM) in early and advanced stages of DKD.

Source: Background/objectives

Abstract: What methods does the paper describe?

Seventy-six T2DM patients, 28 in early DKD stage (urine albumin to creatinine ratio (UACR)): 30 to 299 mg/g: group 1), and 48 in advanced DKD stage (UACR ≥300 mg/g: group 2), participated.

Source: Methods

Abstract: Results

In group 1, prevalence of CAN was 46% versus 75% in group 2 (p=0.01). 25(OH)D was lower in group 2 (26.3 ± 9.8 vs 30.0 ± 8.0; p<0.05) and, in this group, those with CAN vs without CAN showed lower 25(OH)D (27.8 ± 8.3 vs 32 ± 6.3; p<0.05). Only in group 2, patients with VD deficiency (<no><20</no> ng/ml) vs normal, showed worse CAN parameters, particularly VLF (65.5 (46-104) vs 309 (106.5-682.5), p<0.01), SDNN (10.5 (8-17.5) vs 28.5 (13-48), p<0.05) and Valsalva Maneuver (1.12 ± 0.04 vs 1.30 ± 0.21, p<0.05).

We have found a correlation between VD concentration and CAN prevalence (r = -0.3, p<0.05). Logistic regression showed that VD concentration <no><20</no> ng/ml increased 24 times the chance of abnormal VLF (R²: 0.38; OR: 24.1; 95% (CI: 2.6 to 222); p<0.01).

Source: Results

Abstract: Conclusions

To our knowledge, this is the first study to demonstrate an association between lower VD and CAN in T2DM and advanced DKD.

Source: Conclusions
Authors’ abstract

Background/objectives

Cardiovascular autonomic neuropathy (CAN) may be associated with other diabetes mellitus-related complications. In addition, lower vitamin D (VD) levels have been associated with diabetic kidney disease (DKD) and diabetic neuropathy. We evaluated the relationship between serum VD and CAN in patients with type 2 Diabetes Mellitus (T2DM) in early and advanced stages of DKD.

Methods

Seventy-six T2DM patients, 28 in early DKD stage (urine albumin to creatinine ratio (UACR)): 30 to 299 mg/g: group 1), and 48 in advanced DKD stage (UACR ≥300 mg/g: group 2), participated.

Results

In group 1, prevalence of CAN was 46% versus 75% in group 2 (p=0.01). 25(OH)D was lower in group 2 (26.3 ± 9.8 vs 30.0 ± 8.0; p<0.05) and, in this group, those with CAN vs without CAN showed lower 25(OH)D (27.8 ± 8.3 vs 32 ± 6.3; p<0.05). Only in group 2, patients with VD deficiency (<no><20</no> ng/ml) vs normal, showed worse CAN parameters, particularly VLF (65.5 (46-104) vs 309 (106.5-682.5), p<0.01), SDNN (10.5 (8-17.5) vs 28.5 (13-48), p<0.05) and Valsalva Maneuver (1.12 ± 0.04 vs 1.30 ± 0.21, p<0.05).

We have found a correlation between VD concentration and CAN prevalence (r = -0.3, p<0.05). Logistic regression showed that VD concentration <no><20</no> ng/ml increased 24 times the chance of abnormal VLF (R²: 0.38; OR: 24.1; 95% (CI: 2.6 to 222); p<0.01).

Conclusions

To our knowledge, this is the first study to demonstrate an association between lower VD and CAN in T2DM and advanced DKD.

Publication and source details

Original title: Vitamin D and cardiovascular autonomic neuropathy in type 2 diabetes mellitus according to diabetic kidney disease stage

João Felício; Ester Chambouleyron; Valéria Nascimento; Isabel Fernandes; Lícia Ruivo; Maria Vitória Hupp; Lilian Silva; Natércia de Queiroz; Franciane de Melo; Ana Carolina de Souza; Márcia dos Santos; Lorena de Moraes; Mayana Barros; Danielle Pinheiro; Maria Eduarda do Carmo; Beatriz Lobo; Pedro Piani; Ana Regina Motta; Melissa dos Reis; Valéria Suênya Leal; Priscila de Figueiredo; Karem Felício

Frontiers in Endocrinology · 2026

* Correspondence: João Felício, ufpapesquisareg@gmail.com

†These authors have contributed equally to this work

Copyright © 2026 Felício, Chambouleyron, Nascimento, Fernandes, Ruivo, Hupp, Silva, de Queiroz, de Melo, de Souza, dos Santos, de Moraes, Barros, Pinheiro, do Carmo, Lobo, Piani, Motta, dos Reis, Leal, de Figueiredo and Felício.2026Felício, Chambouleyron, Nascimento, Fernandes, Ruivo, Hupp, Silva, de Queiroz, de Melo, de Souza, dos Santos, de Moraes, Barros, Pinheiro, do Carmo, Lobo, Piani, Motta, dos Reis, Leal, de Figueiredo and Felíciohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:25:55.888944+00:00

DOI: 10.3389/fendo.2026.1810159 · PMC13124521